Cargando…
Investigation of the inhibition effect of 1,2,3,4,6-pentagalloyl-β-D-glucose on gastric cancer cells based on a network pharmacology approach and experimental validation
BACKGROUND: Gastric cancer (GC) is ranked as the third leading cause of cancer-related mortality worldwide. 1,2,3,4,6-Pentagalloyl-β-D-glucose (β-PGG) has various pharmacological activities and has been shown to suppress cancer development. However, the mechanism by which β-PGG inhibits gastric canc...
Autores principales: | Bi, Jing-hui, Jiang, Yu-han, Ye, Shi-jie, Wu, Min-rui, Yi, Yang, Wang, Hong-xun, Wang, Li-mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9383036/ https://www.ncbi.nlm.nih.gov/pubmed/35992839 http://dx.doi.org/10.3389/fonc.2022.934958 |
Ejemplares similares
-
1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection
por: Chen, Rui Hong, et al.
Publicado: (2021) -
1,2,3,4,6-Pentagalloyl glucose of Pistacia lentiscus can inhibit the replication and transcription processes and viral pathogenesis of SARS-COV-2
por: Samandar, Farzaneh, et al.
Publicado: (2022) -
In vitro anti-hepatocellular carcinogenesis of 1,2,3,4,6-Penta-O-galloyl-β-D-glucose
por: Jiang, Yu-han, et al.
Publicado: (2023) -
Biomechanical Restoration Potential of Pentagalloyl Glucose after Arterial Extracellular Matrix Degeneration
por: Patnaik, Sourav S., et al.
Publicado: (2019) -
Animal Model Dependent Response to Pentagalloyl Glucose in Murine Abdominal Aortic Injury
por: Anderson, Jennifer L., et al.
Publicado: (2021)